ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,795
0,20%
Bitcoin
59 993,88
1,47%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Eupraxia Pharmaceuticals Inc (EPRX)

  7. Eupraxia Pharmaceuticals Inc (EPRX) Actualités

EPRX Eupraxia Pharmaceuticals Inc

3,72
0,03 (0,81%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Eupraxia Pharmaceuticals Inc EPRX Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,03 0,81% 3,72 21:59:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,70 3,69 3,80 3,72 3,69
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
11/4/202413:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/4/202413:00PRNCAEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/4/202413:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03/4/202423:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01/4/202423:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/3/202413:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/3/202414:41PRNCAL'Organisme canadien de réglementation des investissements..
12/3/202414:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/3/202414:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11/3/202421:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11/3/202421:06PRNCASuspension de la négociation par l'Organisme canadien de..
11/3/202421:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05/2/202423:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/2/202413:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/1/202413:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
09/1/202400:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
14/11/202323:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01/11/202312:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11/10/202313:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
11/9/202321:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07/9/202323:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
06/9/202323:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
19/8/202301:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
11/8/202323:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04/8/202313:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26/6/202313:00PRNUSEupraxia Pharmaceuticals Reports Positive Topline Data in..
16/6/202300:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
13/6/202317:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13/6/202313:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13/6/202313:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08/6/202313:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
25/5/202313:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
18/5/202313:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
11/5/202313:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..

Dernières Valeurs Consultées

TSX
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés